General procedure for the synthesis of compounds 4 or 5: A mixture of isatin/isatinimine 1/3 (1 equiv), furan-2-(3H)-one 2 (1.2 equiv) in 2.5 mL THF was added the DABCO (0.05 equiv) and stirred at 25 o C for 2.5-5 hours. The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was quenched by adding water. The aqueous layer was extracted by ethyl acetate (3×10 mL). Then, the combined organic layers were washed with brine, dried over anhydrous Na 2 SO 4 and concentrated under reduce pressure. The crude product was then purified by silica gel column chromatography (60-120 mesh) using ethyl acetate/hexane as eluent to yield the corresponding products. All the obtained products (4a-4i and 5a-5h) were characterized by 1 H NMR, 13 C NMR, and Mass and IR spectral data.
Characterization Data of All Compounds 3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4a, Table 2):
Following the general procedure, the reaction of isatin 1a (0.073 g, 0.50 mmol, 1.0 equiv) with furan-2-(3H)-one 2 (0.050 mg, 0.60 mmol, 1.2 equiv) and DABCO (0.003 g, 0.025 mmol, 0.05 equiv) afforded 4a (95%, 0.109 g) as white solid; 84.3, 109.1, 120.2, 121.8, 124.3, 128.6, 128.8, 141.2, 152.5, 170.6, 175.5 (major); 83.2, 85.0, 120.9, 121.2, 123.3, 124.9, 126.5, 129.7, 140.6, 152.0, 171.2, 174.3 (minor) ; IR (KBr) ν = 3480, 3995, 3103, 1765, 1723, 1615, 1466, 1169, 753 Table  2 ):
1-benzyl-3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4b,
6.04 (dd, J = 1.7, 3.9 Hz, 1H), 6.77-6.81 (m, 1H), 7.06-7.10 (m, 1H), 7.58-7.61 (m, 1H), 7.84-7.88 (m, 2H) , 10.30 (s, 1H) (minor); 13 C NMR (75 MHz, CDCl 3 +DMSO-d 6 ): δ 82. 8, 84.0, 111.8, 112.2, 114.8, 115.1, 121.9, 137.2, 152.2, 158.0, 170.5, 175.3 (major); 83.0, 83.9, 111.0, 111.3, 114.7, 115.0, 121.3, 136.6, 151.8, 158.6, 171.0, 174 3-hydroxy-1-methyl-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4d, 8, 82.7, 84.0, 107.2, 120.8, 121.7, 123.9, 124.3, 128.9, 142.5, 152.4, 170.4, 173.6 (major); 24.7, 82.9, 84.1, 121.1, 121.4, 123.0, 124.1, 125.8, 128.7, 142.4, 151.8, 170.9, 174.2 (minor) 1-butyl-3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4e, 19.2, 28.8, 39.0, 75.4, 83.8, 108.8, 121.5, 122.6, 125.2, 125.8, 130.0, 143.2, 154.5, 171.6, 174.6; IR (KBr) ν = 3375, 3084, 2927 , 2862 , 1760 , 1700 , 1610 , 1462 1-allyl-3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4f, 83.7, 109.2, 116.4, 121.7, 122.7, 125.1, 125.6, 129.9, 131.2, 142.9, 154.5, 171.5, 174.4; IR (KBr) ν = 3362, 3099, 2930 , 1789 , 1755 , 1708 , 1612 , 1467 , 1377 , 1116 , 1048 1-allyl-5-fluoro-3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (4g, Table 2 3-hydroxy-3-(5-oxo-2,5-dihydrofuran-2-yl)-1-propylindolin-2-one (4h, tert-butyl 3-hydroxy-2-oxo-3-(5-oxo-2,5-dihydrofuran-2-yl)indoline-1-carboxylate (4i, 115.4, 123.7, 124.8, 124.6, 125.3, 131.0, 140.0, 148.3, 151.2, 171.5, 173.9 (major); 29.6, 76.0, 84.2, 85.3, 115.4, 123.6, 124.4, 124.6, 125.3, 131.1, 140.0, 148.3, 151.5, 171.5, 173.9 (minor) 3-(3-chlorophenylamino)-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (5a, 
3-(5-oxo-2,5-dihydrofuran-2-yl)-3-(phenylamino)indolin-2-one (5b, Table 3):
Following the general procedure, the reaction of 3-(phenylimino) indolin-2-one 3b ( 9, 83.8, 110.3, 113.8, 117.7, 121.2, 123.0, 124.2, 125.2, 128.7, 129.9, 142.3, 145.6, 154.3, 171 
3-(5-oxo-2,5-dihydrofuran-2-yl)-3-(2,4,5-trichlorophenylamino)indolin-2-one (5c, Table 3):
Following the general procedure, the reaction of 3-(2,4,5-tri chloro phenylimino) indolin- 7, 83.8, 109.7, 121.0, 121.6, 121.9, 122.5, 124.5, 125.4, 126.3, 129.7, 129.9, 141.8, 142.4, 154.2, 154.6, 171.7, 176.2 (major); 76.5, 85.0, 109.7, 121.0, 121.6, 121.9, 122.5, 124.5, 125.4, 126.3, 129.7, 129.9, 141.8, 142.4, 154.2, 154.6, 172.3, 174.9 (minor) 
3-(4-methoxyphenylamino)-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (5d, Table 3):
Following the general procedure, the reaction of 3-(4-methoxy phenylimino) indolin-2-one 66.7, 83.9, 110.1, 114.1, 116.3, 121.2, 122.8, 124.4, 125.3, 129.8, 139.1, 142.4, 152.2, 154.4, 171.3, 176.4 (major); 55.3, 66.2, 83.9, 109.9, 114.0, 115.1, 121.2, 122.6, 124.4, 125.3, 130.0, 139.2, 140.1, 152.3, 154.4, 171.3, 176.4 (minor) 
3-(5-oxo-2,5-dihydrofuran-2-yl)-3-(o-tolylamino)indolin-2-one (5e, Table 3):
Following the general procedure, the reaction of 3-(2-methyl phenylimino) indolin-2-one 3e (0.118 g, 0.50 mmol, 1.0 equiv) with furan-2-(3H)-one 2 (0.050 mg, 0. 8, 65.9, 83.9, 110.1, 112.0, 118.3, 121.1, 122.6, 123.9, 124.6, 125.1, 126.1, 129.8, 130.0, 142.2, 142.8, 154.6, 171.2, 176.2; IR (KBr) 3-(3-fluorophenylamino)-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (5f, Table 3):
Following the general procedure, the reaction of 3-(3-fluoro phenylimino) indolin-2-one 3f
(0.120 g, 0.50 mmol, 1.0 equiv) with furan-2-(3H)-one 2 (0.050 mg, 0. 100.0, 103.9, 110.0, 110.4, 121.4, 123.2, 123.7, 125.3, 130.2, 142.2, 147.5, 154.0, 161.7, 163.7, 171.2, 177.7 (major); 66.7, 84.4, 99.7, 103.5, 109.6, 110.5, 122.3, 123.3, 124.4, 125.2, 130.3, 141.3, 147.7, 152.7, 161.7, 163.7, 171.9, 174.5 (minor) 6, 83.7, 110.5, 112.9, 119.2, 119.7, 121.7, 123.1, 123.8, 125.0, 127.6, 129.3, 130.2, 140.7, 141.8, 153.6, 171.7, 174.8; IR (KBr) ν = 3326, 3087, 3032, 2878 , 2816 , 1784 , 1726 , 1468 
3-(4-chlorophenylamino)-3-(5-oxo-2,5-dihydrofuran-2-yl)indolin-2-one (5h, Table 3):
Following the general procedure, the reaction of 3-(4-chloro phenylimino) indolin-2-one 3h 110.3, 112.3, 120.1, 121.9, 123.6, 124.2, 124.6, 128.5, 129.6, 138.4, 143.0, 150.8, 170.4, 174.0; IR (KBr) ν = 3365, 3081, 3029, 2869 , 2820 , 1789 , 1715 , 1471 ; MS-ESI: m/z = 363 [M+Na] +
